Detection of viral and bacterial respiratory pathogens in patients with cystic fibrosis

Sacha Stelzer-Braid1, Harpreet Johal, Kelly Skilbeck

  • 1Virology Division, SEALS Microbiology, Prince of Wales Hospital, Randwick, NSW 2031, Australia.

Insights

Viral respiratory infections, particularly rhinoviruses, are linked to cystic fibrosis exacerbations in children. Dual infections may worsen symptoms, highlighting the need to study viral mechanisms in cystic fibrosis care.

Area of Science:

  • Pediatric Respiratory Medicine
  • Infectious Diseases
  • Cystic Fibrosis Research

Background:

  • Viral respiratory infections frequently trigger exacerbations in cystic fibrosis patients.
  • Understanding the specific viral pathogens involved is crucial for managing cystic fibrosis.

Purpose of the Study:

  • To investigate the association between viral and bacterial infections and clinical exacerbations in children with cystic fibrosis.
  • To identify specific pathogens linked to cystic fibrosis exacerbations.

Main Methods:

  • Development and application of viral and bacterial multiplex PCR assays.
  • Analysis of nasal swab samples from pediatric cystic fibrosis patients.

Main Results:

  • Rhinoviruses were frequently detected in children with cystic fibrosis.
  • Viral pathogens were more common than bacterial pathogens.
  • Parainfluenza virus 3 was associated with exacerbations, often with co-infection by rhinovirus.
  • No significant association was found for other tested viruses or bacteria with exacerbations.

Conclusions:

  • Viral infections, especially rhinoviruses, are clearly associated with cystic fibrosis exacerbations.
  • Dual viral infections may increase symptom severity.
  • Further research is needed to elucidate the mechanisms of viral-induced exacerbations in cystic fibrosis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...